Optimization of anti-pseudomonal antibiotics for cystic fibrosis pulmonary exacerbations: II. Cephalosporins and penicillins update

Pediatr Pulmonol. 2017 Jul;52(7):863-865. doi: 10.1002/ppul.23713. Epub 2017 Jun 7.

Authors

Jeffery T Zobell^{1

2}, Kevin L Epps³, David C Young⁴

Affiliations

¹ Pharmacy, Intermountain Primary Children's Hospital, Salt Lake City, Utah.
² Intermountain Cystic Fibrosis Pediatric Center, Salt Lake City, Utah.
³ Mayo Clinic, Jacksonville, Florida.
⁴ University of Utah College of Pharmacy, Salt Lake City, Utah.

PMID: 28590594
DOI: 10.1002/ppul.23713

No abstract available

Publication types

Letter
Comment

MeSH terms

Anti-Bacterial Agents
Cephalosporins*
Cystic Fibrosis
Humans
Penicillins*
Pseudomonas Infections
Pseudomonas aeruginosa

Substances

Anti-Bacterial Agents
Cephalosporins
Penicillins